| Anesthetics and Auditory, Visceral, and Heat Evoked Potentials (NCT00534586) | Technical University of Munich | 2005-12-01 |
| A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg (NCT00726414) | Mutual Pharmaceutical Company, Inc. | 2005-12-01 |
| Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers (NCT02253862) | Boehringer Ingelheim | 2005-12-01 |
| Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection (NCT00542217) | HiberCell, Inc. | 2005-12-01 |
| Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg (NCT00649623) | Mylan Pharmaceuticals Inc | 2005-12-01 |
| Effects of Butyrate Enemas on Colonic Health (NCT00693355) | Maastricht University Medical Center | 2005-12-01 |
| Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg (NCT00648219) | Mylan Pharmaceuticals Inc | 2005-12-01 |
| Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects (NCT02248883) | Boehringer Ingelheim | 2005-12-01 |
| Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg (NCT00648934) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers (NCT02253875) | Boehringer Ingelheim | 2005-11-01 |
| Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System (NCT00647842) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| Levetiracetam 750 mg Tablets Under Non-Fasting Conditions (NCT00849485) | Teva Pharmaceuticals USA | 2005-11-01 |
| Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers (NCT02266537) | Boehringer Ingelheim | 2005-11-01 |
| Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections (NCT00599430) | Danisco | 2005-11-01 |
| Effects of Statins on Pro- and Antioxidant Status : Link With Statin-Associated Myopathy. (NCT00285181) | University Hospital, Montpellier | 2005-11-01 |
| Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg (NCT00649155) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg (NCT00649467) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| Endophenotype for Alcohol Misuse in Healthy Minority Populations (NCT00256451) | University of Pennsylvania | 2005-11-01 |
| Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg (NCT00648154) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| GI Interlab 2 Study: Measuring the Glycaemic Index (GI) of Foods (NCT00260858) | Glycaemic Index Testing, Inc. | 2005-11-01 |
| Comparison of Two Insulin Detemir Formulations in Healthy Volunteers (NCT01498926) | Novo Nordisk A/S | 2005-11-01 |
| Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers (NCT02253849) | Boehringer Ingelheim | 2005-11-01 |
| Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg (NCT00649740) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| Nutrition and Cognition in Indian Children (NCT00467909) | St. John's Research Institute | 2005-11-01 |
| A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects (NCT00311519) | Halozyme Therapeutics | 2005-11-01 |
| A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions (NCT00864071) | Actavis Inc. | 2005-11-01 |
| Effect of Lutein in S-26 Gold On Growth And Safety (NCT00913406) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-11-01 |
| Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects (NCT00864500) | Actavis Inc. | 2005-11-01 |
| Muscular Training-induced Changes in COPD (NCT03169270) | Hospital Clinic of Barcelona | 2005-11-01 |
| Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg (NCT00648063) | Mylan Pharmaceuticals Inc | 2005-11-01 |
| PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram (NCT00250172) | National Institute of Mental Health (NIMH) | 2005-10-31 |
| In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male Volunteers (NCT02260024) | Boehringer Ingelheim | 2005-10-01 |
| Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning (NCT00611975) | Weill Medical College of Cornell University | 2005-10-01 |
| The Circadian Rhythm of Urine Output in Healthy Infants (NCT00232401) | Aarhus University Hospital | 2005-10-01 |
| Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg (NCT00649324) | Mylan Pharmaceuticals Inc | 2005-10-01 |
| Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions (NCT00778180) | Ranbaxy Laboratories Limited | 2005-10-01 |
| Levetiracetam 750 mg Tablets Under Fasting Conditions (NCT00849862) | Teva Pharmaceuticals USA | 2005-10-01 |
| In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects (NCT02256722) | Boehringer Ingelheim | 2005-10-01 |
| Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers (NCT02182076) | Boehringer Ingelheim | 2005-10-01 |
| The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects (NCT00864240) | Actavis Inc. | 2005-10-01 |
| A Study of the Effect of Mental Health Promotion on Mental Health Index (NCT00261638) | National Taiwan University Hospital | 2005-10-01 |
| Respiratory Muscle Strength in Bronchiectasis: Repeatability and Reliability (NCT00487149) | University of Ulster | 2005-10-01 |
| Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans (NCT00281710) | Regional Hospital Holstebro | 2005-10-01 |
| A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions (NCT00864435) | Actavis Inc. | 2005-10-01 |
| A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions (NCT00830336) | Teva Pharmaceuticals USA | 2005-10-01 |
| Effects of Peptides Derived From Fermented Milk on Blood Pressure Regulation System in Healthy Volunteers. (NCT00399737) | Assistance Publique - Hôpitaux de Paris | 2005-10-01 |
| Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg (NCT00650351) | Mylan Pharmaceuticals Inc | 2005-10-01 |
| Changes in Bleeding and Clotting During the Menstrual Cycle (NCT00480545) | The University of Texas Health Science Center, Houston | 2005-10-01 |
| A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions (NCT00864149) | Actavis Inc. | 2005-10-01 |
| Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg (NCT00647621) | Mylan Pharmaceuticals Inc | 2005-10-01 |
| Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg (NCT00649662) | Mylan Pharmaceuticals Inc | 2005-10-01 |
| Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions (NCT01164774) | Dr. Reddy's Laboratories Limited | 2005-10-01 |
| Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers (NCT02182154) | Boehringer Ingelheim | 2005-10-01 |
| Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin (NCT00187707) | University of California, San Francisco | 2005-09-01 |
| Ivermectin Solution Bioequivalence Study - With Food (Repeat) (NCT00921219) | Johnson & Johnson Consumer and Personal Products Worldwide | 2005-09-01 |
| Effect of Branched Chain Amino Acids on Muscle (NCT00170144) | Mayo Clinic | 2005-09-01 |
| Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions (NCT00775372) | Ranbaxy Laboratories Limited | 2005-09-01 |
| A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions (NCT00865657) | Actavis Inc. | 2005-09-01 |
| Can Vignettes Be Used to Improve Practice & Outcome (NCT00122148) | US Department of Veterans Affairs | 2005-09-01 |
| Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions (NCT01164761) | Dr. Reddy's Laboratories Limited | 2005-09-01 |
| Dietary Variety Versus Dietary Fat Effects in Energy Intake (NCT00285571) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-09-01 |
| Pharmacokinetics of Salmeterol Via HandiHaler® in Healthy Male Volunteers (NCT02254187) | Boehringer Ingelheim | 2005-09-01 |
| Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions (NCT01179659) | Kremers Urban Development Company | 2005-09-01 |
| Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers (NCT02256813) | Boehringer Ingelheim | 2005-09-01 |
| Effect of Nutrition Labeling on Fast Food Choices (NCT00127660) | University of Minnesota | 2005-09-01 |
| A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions (NCT00865761) | Actavis Inc. | 2005-09-01 |
| Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe (NCT00314522) | AHS Cancer Control Alberta | 2005-09-01 |
| The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers (NCT02183623) | Boehringer Ingelheim | 2005-09-01 |
| A Primary Care Intervention for Weight Management (NCT00271193) | Kaiser Permanente | 2005-09-01 |
| Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects (NCT00230516) | AstraZeneca | 2005-09-01 |
| Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers (NCT02183506) | Boehringer Ingelheim | 2005-09-01 |
| Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg (NCT00647816) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Anastrozole 1 mg Tablets Under Fed Conditions (NCT01183390) | Teva Pharmaceuticals USA | 2005-09-01 |
| Efficacy of 3 Nutritional Supplements to Improve Diverse Outcomes in Children Under 2 Years of Age and Pregnant Women (NCT00531674) | Mexican National Institute of Public Health | 2005-09-01 |
| Intralumenal Effects on Cholesterol Absorption/Synthesis (NCT00328211) | Children's Hospital Medical Center, Cincinnati | 2005-09-01 |
| Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg (NCT00649987) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Development of Magnetic Resonance (MR) Simulation for Treatment Planning (NCT00314496) | AHS Cancer Control Alberta | 2005-09-01 |
| Specific Effects of Escitalopram on Neuroendocrine Response (NCT00150527) | Queen's University | 2005-09-01 |
| ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency (NCT00407472) | EMD Serono | 2005-09-01 |
| Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions (NCT00775255) | Ranbaxy Laboratories Limited | 2005-09-01 |
| Does Block Play Improve Language Acquisition: A Randomized Trial (NCT00428376) | University of Washington | 2005-09-01 |
| Yoga, Immune Function, and Health (NCT00371397) | Ohio State University | 2005-09-01 |
| Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg (NCT00647608) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg (NCT00649779) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Granisetron 1 mg Tablets Under Fasting Conditions (NCT00834717) | Teva Pharmaceuticals USA | 2005-09-01 |
| Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department (NCT00170105) | Mayo Clinic | 2005-08-01 |
| Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers (NCT00377923) | IBSA Institut Biochimique SA | 2005-08-01 |
| Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions (NCT00779051) | Ranbaxy Laboratories Limited | 2005-08-01 |
| Study to Evaluate Potential Food Effects (NCT00791817) | Procter and Gamble | 2005-08-01 |
| Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions (NCT00779441) | Ranbaxy Laboratories Limited | 2005-08-01 |
| Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive? (NCT00265486) | Rigshospitalet, Denmark | 2005-08-01 |
| Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan (NCT01497587) | Novo Nordisk A/S | 2005-08-01 |
| Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers (NCT02256735) | Boehringer Ingelheim | 2005-08-01 |
| Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions (NCT00778973) | Ranbaxy Laboratories Limited | 2005-08-01 |
| Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors (NCT00511550) | University of California, San Francisco | 2005-08-01 |
| Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions (NCT00779350) | Ranbaxy Laboratories Limited | 2005-08-01 |
| A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI) (NCT00347594) | Bausch & Lomb Incorporated | 2005-08-01 |
| Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS (NCT02180503) | Boehringer Ingelheim | 2005-08-01 |
| Anastrozole 1 mg Tablets Under Fasting Conditions (NCT01182181) | Teva Pharmaceuticals USA | 2005-08-01 |
| Spot Reduction in Male Adults (NCT05794854) | Molde University College | 2005-08-01 |